Patienter behandlet med valsartan havde bedre livskvalitet, påvist ved ændring i livskvalitetsscore (Minnesota Living with Heart Failure Quality of Life score) fra baseline ved effektmål end placebo.
Patients treated with valsartan had a better quality of life as demonstrated by change in the Minnesota Living with Heart Failure Quality of Life score from baseline at endpoint than placebo.